Hong Kong stock abnormal movement | Xian Sheng Pharmaceuticals (02096.HK) opened more than 6% higher and reached a significant cooperation with NextCure, with potential revenue exceeding 700 million US dollars.
According to the "Caijing APP", Sinopharm Group Co., Ltd. (02096.HK) opened more than 6% higher, rising 6.33% to HK$12.76 as of the time of publication, with a turnover of HK$6.81 million.
Latest
